genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
29 March 2018
21 March 2018 Capital Networks - Note on Genedrive's Interim Results
View all reports >
Friday July 13, 2018
genedrive shares push higher as the rapid diagnostics specialist gears up for important year
Thursday June 21, 2018
Genedrive on track to commercialise its diagnostic products
Wednesday June 20, 2018
Genedrive receives grant award for NHS point-of-care test
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-18 genedrive plc
Don't show this again